Market Analysis Report Sevoflurane, Isoflurane and Desflurane Market

Your Catalyst to a Lucrative Business
Sevoflurane, Isoflurane and Desflurane Market Share,
Size,Growth, Key Players, Outlook and Forecasts to 2022 | Hexa
Research
“ The sevoflurane, isoflurane and desflurane market is expected to reach USD
1.5 billion by 2022”
14 December 2018
Overview
The sevoflurane, isoflurane and desflurane market is expected to reach USD 1.5 billion by 2022 in comparison
to USD 1.2 billion in 2014. These three chemicals are inhalation agents and have been used by
anesthesiologists, nurse anesthetists, and anesthesiology assistants on a consistent basis. They are very
strong and cost less, with minimum damage to the ozone layer.
Market Drivers
One of the primary factors, triggering expansion in the sevoflurane, isoflurane and desflurane market
includes cardiovascular and respiratory diseases affecting the geriatric population. Rising cancer, orthopedic,
spinal and gastro-intestinal cases have also furthered the market. Cataract surgery is a major contributor to
the global market and will need a higher production of these chemicals.
Growing accidents and emergency cases also add income to the inhalation anesthes ia market. Universal
insurance coverage as well as constant improvements in medical infrastructure also ensure the development
Follow Us: